Chief Financial Officer · Opus Genetics, Inc. (IRD)

Nirav Jhaveri

FY2024 is the first fiscal year CompBrief holds for Nirav Jhaveri as a named executive officer of Opus Genetics; the record below is that year, complete. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2024

$1,344,069

Salary $362,874Stock awards $372,400

1st of 3 named executive officers at Opus Genetics by FY2024 total.

3 named officers on file for Opus Genetics, FY2024

Nirav Jhaveri’s pay file — $29

  • 1 fiscal year of pay, line by line
  • IRD’s disclosed peer group of 10 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Opus Genetics’s whole pay program stands against its peers

  • Opus Genetics’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on IRD→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 2, 2025 (DEF 14A).

Free

Get Nirav Jhaveri’s full pay file as a PDF — free

More than this page: up to 10 years of Nirav’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Nirav Jhaveri compensation by year

Opus Genetics Summary Compensation Table · the one fiscal year held
In US dollars, as Opus Genetics reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2024
Salary$362,874
Bonus$0
Stock awards$372,400
Option awards$445,467
Non-equity incentive$155,128
Pension and deferred compensation$0
All other$8,200
Total$1,344,069

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Opus Genetics, Inc. DEF 14A filed April 2, 2025, accession 0001999371-25-003703, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Opus Genetics, Inc. filed document, accession 0001999371-25-003703. Every figure is read from that document and cited to the page and table it appears in. Filed April 2, 2025.

Equity holdings

unvested awards at FY2024 year-end
TypeUnvested unitsValue at year-endExercise price
RSU140,000$166,600—
Option210,000—$2.66

Per the Outstanding Equity Awards at Fiscal Year-End table in Opus Genetics, Inc.'s FY2024 proxy; value at the fiscal year-end close, as the company printed it.

Opus Genetics’s named executive officers, FY2024

as the company reported each
Named executive officerRoleFY2024 total
Nirav Jhaveri · this pageChief Financial Officer$1,344,069
Ashwath JayagopalChief Scientific and Development Officer$1,242,154
George MagrathChief Executive Officer$889,238

The full Opus Genetics compensation record

free company brief

This page is one person within Opus Genetics's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the Opus Genetics proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Opus Genetics's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Nirav Jhaveri's compensation dossier · One-time report. No refunds.